LC-TEM provides a window into the nanoscale
26 April 2018 | By European Pharmaceutical Review
Researchers create a device that allows more electron beam to pass through liquid samples...
List view / Grid view
Analytical techniques
FDA authorises new use of test to identify the emerging pathogen Candida auris
25 April 2018 | By European Pharmaceutical Review
The FDA has authorised the first test to identify the emerging pathogen Candida auris, which can cause serious infections in hospitalised patients...
New C2MAP automated pretreatment module
20 April 2018 | By Shimadzu
Complete LC/MS solution for cell culture analysis...
Eurofins: Designed to give clients laboratory services support
19 April 2018 | By European Pharmaceutical Review
Eurofins’ PSS Insourcing Solutions® (PSS) employs and manages full-time scientists, managers and support staff to perform a defined scope of work at a client’s facility.
Charles River: Data drives every decision in the lab to support confident decisions
19 April 2018 | By European Pharmaceutical Review
Charles River Microbial Solutions believes data drives every decision in the lab, so ensuring it is accurate, relevant, and reliable is critical to support confident decisions on product quality and safety.
Associates of Cape Cod: Comprehensive consultation, validation, training, and support
19 April 2018 | By European Pharmaceutical Review
As the pioneers of the Limulus amebocyte lysate (LAL) testing methodology, Associates of Cape Cod, Inc., (ACC), specialises in bacterial endotoxin and (1→3)-ß-D-glucan detection, using Food and Drug Association-licensed chromogenic, turbidimetric and gel-clot reagent technologies.
Contrast-enhanced subharmonic imaging detects prostate cancers
17 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A test of contrast-enhanced subharmonic imaging has shown promise in detecting prostate cancers that were not identified by MRI...
Guide to Testing
17 April 2018 | By European Pharmaceutical Review
In this edition, five leading testing service providers explain how they cater for the pharmaceutical industry’s changing needs.
Issue #2 2018 – Digital Version
12 April 2018 | By European Pharmaceutical Review
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.
Bruker launches new FT-IR R&D Spectrometer INVENIO™
12 April 2018 | By Bruker
Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications...
Bruker introduces the new CTX™ Portable XRF Analyzer
12 April 2018 | By Bruker
Bruker today introduces the new CTX™ X-ray fluorescence (XRF) elemental analyzer. The portable Counter Top XRF (CTX) is small, light-weight, safety-interlocked, and battery operated. At less than 7 kilograms in weight, the self-contained CTX is truly portable, and has a small footprint of 14 cm in width...
Hot-Stage Microscopy
12 April 2018 | By METTLER TOLEDO
In this webinar, we will present Thermo-Optical Analysis (TOA), also known as hot-stage microscopy, and some typical applications in the field of speciality chemicals and pharmaceuticals...
Material Characterization by Thermal Analysis
12 April 2018 | By METTLER TOLEDO
Thermal Analysis comprises of a group of techniques that measure the physical or chemical properties of a sample as a function of temperature or time while it is heated, cooled or held at a constant temperature...
Robotics takes mass spec to the third dimension for pharma applications
11 April 2018 | By European Pharmaceutical Review
Scientists report that by combining a robotic arm and mass spectrometry can potentially open up new branches of pharmaceutics...
Blood test found to predict onset of TB up to two years in advance
6 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB...
Follow: